| Once-Daily Tacrolimus Shows Good Efficacy in 2-Year Follow-Up of Renal ... - DG News |
|
|
DG NewsSecondary endpoints included adverse events (AEs), renal function and the incidence of biopsy proven acute rejection (BPAR). ...Late Conversion to Sirolimus in Liver Transplant Recipients is a Safe Clinical ... read more |